Compare VERI & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VERI | ALPS |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.2M | 66.6M |
| IPO Year | 2017 | 2024 |
| Metric | VERI | ALPS |
|---|---|---|
| Price | $1.35 | $0.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 57.9K |
| Earning Date | 04-15-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $92,637,000.00 | N/A |
| Revenue This Year | $52.20 | N/A |
| Revenue Next Year | $3.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.76 | $0.23 |
| 52 Week High | $9.42 | $1.72 |
| Indicator | VERI | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 62.80 | 46.12 |
| Support Level | $1.27 | $0.38 |
| Resistance Level | $1.56 | $0.44 |
| Average True Range (ATR) | 0.10 | 0.02 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 77.01 | 34.34 |
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has presence in the United States, the United Kingdom, France, Australia, Israel, and India.
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.